Chapter 188 Management of Spinal Cord Tumors and Arteriovenous Malformations
Intramedullary Spinal Cord Tumors
History of Surgery
The first reported attempt to resect an intramedullary spinal cord tumor was described in 1890.1 The patient died in the early postoperative period. As a result, these tumors were considered essentially nonsurgical lesions until the first described successful resection of an intramedullary ependymoma in 1907 by Anton von Eiselsberg. After undergoing a gross total resection, the patient regained and maintained ambulation with long-term follow-up.2
As the new wave of intramedullary spinal cord tumor surgery progressed, Elsberg and Beer advocated attempts at gross total resection by identifying safe tissue planes with blunt dissection.3 They reported an aborted first attempt at resection of an intramedullary tumor in which hemodynamic instability was encountered after myelotomy was performed. Upon returning to the operating room 1 wk later, Elsberg found that the tumor had extruded through the myelotomy defect with minimal spinal cord manipulation, and the patient regained function. Subsequently, Elsberg advocated such a two-stage approach for all intramedullary tumors in his seminal text, Diagnosis and Treatment of Surgical Diseases of the Spinal Cord and Its Membranes, in 1916.4 While there are still many surgeons who practice this “two-stage” approach, technological advances have allowed many more intramedullary lesions to be resected with good outcomes in one stage. Further series demonstrated reliably that ependymomas are more likely to be safely completely resected, while astrocytomas frequently lack a necessary clear plane between neoplastic and normal tissue (Table 188-1).
Significant Technical Advances
Technical advances account for a large part of the reason that intramedullary tumors are now seen as surgically treatable diseases. The development of the binocular operating microscope in the 1920s, and its first neurosurgical use by Theodore Kurze, revolutionized all aspects of neurosurgery.5 It has become absolutely mandatory in the resection of intramedullary lesions.
Bipolar cautery was first developed in the 1930s and expanded in use with Leonard Malis.6 It allowed for the precise coagulation of tumor vessels while sparing vessels supplying the cord. It also directed electrical current between two forceps tips, protecting surrounding neural tissue from thermal injury. It is indispensable in identifying the natural tumor/cord cleavage plane, if one exists.
Advanced Imaging
Myelography was the gold standard in diagnosis of spinal cord tumors until the advent of MRI. MRI was developed in the 1970s by teams of scientists, and was being applied to the spinal cord by the 1980s. Previously, indirect evidence of spinal cord tumor included cord expansion or myelographic block. With MRI, the spinal cord and tumor tissue could be directly visualized, and described by their signal characteristics.7 As a result, pre-operative diagnosis and planning can often be accomplished, and help direct the care of the patient. MRI is also useful in distinguishing non-neoplastic and nonsurgical lesions from surgical lesions, sparing unnecessary risk for many patients.8 Preoperative diffusion tensor imaging (DTI) tractography may be able to help determine which tumors will have a clear plane of demarcation with non-neoplastic tissue, and which may then safely be resected.9,10 Intraoperative imaging with ultrasound can help localize the optimal site for myelotomy,11 and intraoperative MRI may eventually be helpful to assess the extent of resection.
Intraoperative Neurophysiological Monitoring
Intraoperative neurophysiological monitoring plays a crucial role in the safe resection of intramedullary lesions. Somatosensory evoked potentials (SSEPs), used intraoperatively since the 1970s, record the electrical conductivity along the dorsal columns. Thus they can be used to help identify the midline myelotomy site if the gross anatomy and visual landmarks are found to be distorted. Once the myelotomy is made, it is not unusual to lose SSEP recording, which typically correlates with a loss of vibration and proprioception in the appropriate limbs. With time and rehabilitation, patients learn to compensate for this lost function and can resume normal activities. Use of intraoperative SSEP prior to making the myelotomy may allow for precise identification of the midline between the two dorsal columns and may decrease the morbidity from injury to this tract.12
Transcranial MEP can also be recorded by an epidural electrode located distal to the resection level. This measures the D wave in a quantitative manner, allowing for graded rather than all-or-none interpretation of the electrical signals. It can be recorded with no detectable muscle movement and thus can be monitored continuously during resection. A drop in amplitude greater than 50% is considered significant and warrants a pause in the surgery, at least until signals recover. A surgeon may aggressively seek out a dissection plane as long as the D wave remains stable. Typically, a loss of peripheral muscle MEP with preserved epidural D wave indicates a transient loss of function that may be severe but is likely to recover.13,14
Surgical Technique
In 1962, Turnbull stated: “A surgeon exploring a spinal cord for a suspected intramedullary tumor must be prepared to face a formidable problem and also have the courage of conviction to make every attempt to remove the tumor. Anything less than this, with a cursory inspection of the spinal cord or aspiration thereof, can only create problems of a more complex nature for the subsequent surgical effort to remove such tumors.”15 These words remain true and are the guiding principle in intramedullary spinal cord tumor surgery today.
Surgery remains the primary treatment for intramedullary tumors. Radiotherapy has little to offer as a primary treatment, even for malignant tumors. Radiation treatment has its most significant role as adjuvant treatment of World Health Organization (WHO) grades III and IV tumors.16,17 Regarding the timing of surgery, there is little to be gained by allowing further tumor growth prior to offering surgery. The surgical results are generally predicated on the preoperative condition of the patient, no matter how large the tumor. If the patient preoperatively has minimal neurological findings, then the postoperative course should be gratifying, especially if the tumor can be resected grossly. Those patients who arrive for surgery with significant preoperative deficits may regain little of their lost function even after a technically successful operation.
The dorsal surface of the cord at the area of greatest enlargement is then inspected for the site of the myelotomy. Generally, myelotomies are performed in the midline with a preference for the thinnest and most avascular areas. When the spinal cord is rotated and the midline is difficult to identify, the bilateral dorsal root entry zones can be identified and thereby help to define the midline to perform the myelotomy. Intraoperative dorsal column monitoring can be useful in determining the location for the midline myelotomy.12 At times, however, it is more expeditious to use a paramedian approach (Fig. 188-1).
Following the myelotomy, 6-0 or 7-0 traction sutures are placed through the pial margins on either side and sutured to the edges of the opened dura to expose the interior of the spinal cord (see Fig. 188-1). Generally, the tumor is visible a few millimeters under the dorsal surface of the spinal cord. There is often a soft gliotic interface between the tumor and the spinal cord proper. With the use of an operating microscope, microsurgical techniques, bipolar cautery, small suction tubes, and various dissectors, a plane is developed around the margin of the tumor, taking care to retract primarily on the tumor and not on the spinal cord. Gentle use of plated bayoneted forceps can help tease out natural planes between normal and neoplastic tissue. The surgeon works to one or the other end of the tumor. At the pole where the tumor is the narrowest, it may be possible to grasp the end and gently extract it from the interior of the cord. All the fine vascular adhesions to the spinal cord, especially on the ventral aspect of the tumor, should be cauterized with bipolar cautery and sharply divided. No blunt dissection should be carried out in areas where vascular channels connect the tumor to the spinal cord. Most tumors are relatively avascular and present little of hemorrhage or the loss of control of large blood vessels. It is important to keep the operative field meticulously dry so that the plane between the tumor and the spinal cord may be readily identified (see Fig. 188-1).
If the tumor is too large to remove en bloc or necessitates too much retraction on the spinal cord, its interior may be decompressed. The ultrasonic aspirator may be used to debulk the tumor, facilitating dissection around its capsule and its removal. This has a minor disadvantage of spilling the contents of the tumor into the dissection plane or obscuring the dissection plane by bleeding. In most instances, however, because the tumors are relatively avascular, bleeding is not a major problem, even with the use of the ultrasonic aspirator. Gradually, the entire tumor may be removed. For those tumors (usually astrocytomas) that are infiltrating, a debulking procedure may be valuable, especially in children. Carbon dioxide and argon lasers have also been used for this purpose.18 More recently, the development of sapphire-tipped Nd:YAG (neodymium-doped yttrium-aluminum-garnet) and argon lasers has allowed very focused transmission of energy located at the tip itself. This can be useful in creating the initial myelotomy as well as in dissecting along the tumor-normal interface, with minimal manipulation of the spinal cord.19–21
Cystic collections at the margins of the tumor, as in the case of ependymomas, facilitate the tumor resection. No attempt should be made to remove the wall of the cyst, which is thin and non-neoplastic. If there is any doubt about the totality of removal, small biopsies may be obtained from the margin of the resection and evaluated by frozen sectioning during surgery. In most instances, the margins are well-defined and there is no question about the removal of the tumor (see Figs. 93-4 and 93-6). Malignant tumors such as the glioblastoma respond poorly to surgery and do not appear to respond to radiation therapy. In such cases, heroic lifesaving efforts at cordotomy have been attempted, with dismal results.22,23
A number of aspects concerning the surgical removal and management of intramedullary spinal cord tumors must be emphasized. The surgeon should assume that the majority of all intramedullary cord tumors are benign and resectable. Intraoperative judgment should be based on the gross appearance rather than the histological tumor characteristics, because some low-grade astrocytomas are well-circumscribed and resectable. An inadequate myelotomy may fail to reveal a clear plane, and frozen section specimens made from a small piece of tumor taken through a limited myelotomy may lead to an erroneous tissue diagnosis and thus be misleading. This problem often occurs with tanycytic ependymomas, which may be mistaken for astrocytomas on frozen sections. Therefore, if a clear plane is identified between tumor and normal tissue, the surgeon should continue with the resection as long as electrophysiological monitoring is stable. On the other hand, if the frozen histologic diagnosis is ependymoma, then every attempt must be made to identify a plane, even if one is not initially obvious, and to remove the tumor in total. This is particularly true for large tumors that initially seem infiltrative or that severely compress the surrounding spinal cord such that it is almost unrecognizable. It is sometimes amazing that this thin ribbon of cord tissue can function reasonably well and recover some of its lost function. Therefore, even very large and extensive ependymomas should not deter the surgeon from complete removal. Numerous studies have demonstrated that identification of dissection planes is a major factor in determining the completeness of resection and the eventual long-term prognosis for patients with such tumors.24–26
Clinical Presentation
Although intramedullary tumors occur most commonly in adults,21 a significant incidence has been reported in children.27,28 The symptomatology in both age groups is similar. Slowly growing tumors may displace much of the spinal cord substance before becoming symptomatic, but ultimately an end point is reached when compensatory ability fails and marked neurological deterioration develops rapidly. Persistent pain involving the dorsal root dermatomes in the area of tumor involvement is often the signature of an intramedullary neoplasm. Dysfunction of the posterior column may occur in a progressive fashion, with sensory dysesthesias in the arms, torso, and legs, depending on the site of the intraspinal neoplasm. Sacral sparing may be present and is not an invariable finding with intramedullary neoplasms. Lower motor neuron symptoms and signs usually occur at the level of the tumor. Well-defined central cord syndromes, such as those seen in syringomyelia, with disassociated sensory loss and the classic signs of anterior horn cell involvement may be lacking. Children may present with scoliosis. The symptomatology generally is progressive, with few remissions or exacerbations. Symptoms are usually bilateral, but in rare instances neurological abnormalities are confined to one extremity. The duration of symptoms generally is measured in years, although some neoplasms may have histories of 6 months or less.
Diagnostic Evaluation
MRI, without or with gadolinium, is the standard of care in the diagnostic evaluation of intramedullary tumors of the spinal cord. A fusiform dilatation of the cord in the region of the tumor, with possible associated rostral and caudal cysts, is a typical finding on T1-weighted images. T2 hyperintensity can be seen in the substance of the tumor as well as in associated syrinx or spinal cord edema. Tumors often enhance with the administration of the gadolinium. Ependymomas are typically more circumscribed and enhanced more uniformly with the contrast, whereas fibrillary astrocytomas are somewhat more diffuse and enhance more irregularly. An ependymoma is likely to be more centrally placed within the spinal cord compared to an astrocytoma and is more often associated with rostral and caudal cysts. Hemangioblastomas present on or close to the surface of the cord enhance brilliantly with contrast material and are nearly always associated with a cyst. They may also be associated with syrinx, often at a location distant from the tumor itself. Ependymomas are more commonly found in the cervical cord or conus, whereas astrocytomas are seen in the thoracic spinal cord (Fig. 188-2). DTI is an advanced form of MRI tractography that can provide preoperative assessment of tumor respectability and, to some extent, pathological diagnosis.8,9
In patients for whom MRI may be contraindicated, myelography and computed tomographic myelography can be useful in the preoperative assessment. A fusiform dilatation of the cord in the region of the tumor can be seen, rarely with a complete myelographic block (Fig. 188-3). If a complete block is present, contrast may be instilled from the opposite end of the spinal canal to define the complete extent of the tumor. Dilated venous channels at the caudal aspect of small intramedullary tumors suggest the differential diagnosis of a vascular malformation. This differential is rarely a problem with high-definition MRI, and spinal angiography has not been of additional diagnostic value except for the identification of an intramedullary hemangioblastoma or an intramedullary AVM, which can mimic a vascular intramedullary tumor. Angiography has been carried out in the presence of dilated vessels and has been helpful in the diagnosis of hemangioblastomas and AVMs.29
Surgical Pathology
Intramedullary spinal cord tumors account for one third of primary intraspinal neoplasms.21,30,31 Astrocytomas and ependymomas constitute the largest group of intramedullary tumors and occur with approximately equal frequency, although astrocytomas are more common in childhood and ependymomas are more prevalent in the adult population. The tumors are generally low-grade and extend over many segments of the spinal cord. Astrocytomas most commonly appear in the cervical and thoracic regions of the spinal cord, whereas the ependymomas have a higher incidence in the caudal regions because of their prevalence in the conus medullaris and filum terminale.31
Intramedullary ependymomas often have a distinct plane between the neoplasm and spinal cord tissue. These tumors generally are soft and solid and have a pseudocapsule. They are not highly vascular and may have necrotic areas. Astrocytomas usually are infiltrative, with an ill-defined margin between the neoplasm and the normal spinal cord tissue. Where a well-defined margin between the neoplasm and the normal spinal cord exists, a pseudocapsule is found. This variety is similar to the cerebellar astrocytoma, which has a uniformly soft consistency and minimal vascularity sometimes associated with cysts containing yellow fluid high in protein. At times, astrocytomas may appear to have a plane between the tumor and the normal cord tissue, yet pathologically they demonstrate infiltration (Fig. 188-4).
Ependymomas and astrocytomas are the most common intramedullary spinal cord tumors, comprising 80% to 90% of all such tumors.32